Of mice and men: Use of animal models to identify possible interventions for the prevention of autoimmune type 1 diabetes in humans

Trends in Immunology

Volumn 26, Issue 11, 2005, Pages 603-607

  Serreze, David V ^a   Chen, Yi Guang ^a  

^a JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD3 ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; BONE MARROW; CELL DIFFERENTIATION; HLA SYSTEM; HUMAN; IMMUNOTHERAPY; INSULIN DEPENDENT DIABETES MELLITUS; NATURAL KILLER CELL; NONHUMAN; PANCREAS ISLET BETA CELL; REVIEW; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 28444484693     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2005.08.012     Document Type: Review

References (64)

1. J.P. Mordes Animal models of autoimmune diabetes mellitus D. LeRoith Diabetes mellitus: a fundamental and clinical text 2004 Lippincott Williams and Wilkins 591 610
2. null mice J. Exp. Med. 184 1996 2049 2053
3. P. Silveira The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen specific immunoglobulin receptors Eur. J. Immunol. 32 2002 3657 3666
4. J.P. Mordes Rat models of type 1 diabetes: genetics, environment, and autoimmunity ILAR J. 45 2004 278 291
5. D.V. Serreze, and E.H. Leiter Genes and pathways underlying autoimmune diabetes in NOD mice M.G. von Herrath Molecular Pathology of Insulin Dependent Diabetes Mellitus 2001 Karger Press 31 67
6. M.S. Anderson, and J.A. Bluestone The NOD mouse: a model of immune dysregulation Annu. Rev. Immunol. 23 2005 447 485
7. J.A. Todd, and L.S. Wicker Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models Immunity 15 2001 387 395
8. E. Sebzda Selection of the T cell repertoire Annu. Rev. Immunol. 17 1999 829 874
9. M. Moser Dendritic cells in immunity and tolerance-do they display opposite functions? Immunity 19 2003 5 8
10. D.S. Ucker Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death J. Immunol. 149 1992 1583 1592
11. C. Girao Limits to the differential avidity model of T cell selection in the thymus J. Immunol. 159 1997 4205 4211
12. D.V. Serreze Hematopoietic stem cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C Proc. Natl. Acad. Sci. U. S. A. 90 1993 9625 9629
13. + thymocytes by protective MHC class II molecules J. Immunol. 162 1999 4627 4636
14. J. Verdaguer Two mechanisms for the non-MHC-linked resistance to spontaneous autoimmunity J. Immunol. 162 1999 4614 4626
15. H.T. Kreuwel Defective CD8 T cell peripheral tolerance in nonobese diabetic mice J. Immunol. 167 2001 1112 1117
16. G.F. Beilhack Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice Diabetes 52 2003 59 68
17. D.V. Serreze MHC class II molecules play a role in the selection of autoreactive class I restricted CD8 T cells that are essential contributors to type 1 diabetes development in NOD mice J. Immunol. 172 2004 871 879
18. G.F. Beilhack Prevention of type 1 diabetes with major histocompatibility complex-compatible and nonmarrow ablative hematopoietic stem cell transplants Diabetes 54 2005 1770 1779
19. + regulatory T cells Curr. Opin. Immunol. 13 2001 644 649
20. H. Jonuleit, and E. Schmitt The regulatory T cell family: distinct subsets and their interactions J. Immunol. 171 2003 6323 6327
21. Y. Yang, and P. Santamaria Dissecting autoimmune diabetes through genetic manipulation of non-obese diabetic mice Diabetologia 46 2003 1447 1464
22. S. Lesage Failure to censor forbidden clones of CD4 T cells in autoimmune diabetes J. Exp. Med. 196 2002 1175 1188
23. C-M. Choisy-Rossi Enhanced pathogenicity of diabetogenic T-cells escaping a non-MHC gene controlled near death experience J. Immunol. 173 2004 3791 3800
24. A. Liston Generalized resistance to thymic deletion in the NOD mouse: a polygenic trait characterized by defective induction of Bim Immunity 21 2004 817 830
25. E. Dahlen Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation J. Immunol. 164 2000 2444 2456
26. M. Feili-Hariri, and P.A. Morel Phenotypic and functional characteristics of BM-derived DC from NOD and non-diabetes prone strains Clin. Immunol. 98 2001 133 142
27. J. Strid A defect in bone marrow derived dendritic cell maturation in the nonobese diabetic mouse Clin. Exp. Immunol. 123 2001 375 381
28. S.J. Prasad, and C.C. Goodnow Cell intrinsic effects of non-MHC NOD genes on dendritic cell generation in vivo Int. Immunol. 14 2002 677 684
29. T. Pearson Genetic dissociation of autoimmunity and resistance to costimulation blockade-induced transplantation tolerance in nonobese diabetic mice J. Immunol. 171 2003 185 195
30. A. Jansen Defective maturation and function of antigen-presenting cells in type 1 diabetes Lancet 345 1995 491 492
31. K. Takahashi Impaired yield, phenotype, and function of monocyte-derived dendritic cells in humans at risk for insulin dependent diabetes J. Immunol. 161 1998 2629 2635
32. S.A. Litherland Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitus J. Clin. Invest. 104 1999 515 523
33. M.A. Atkinson, and E.H. Leiter The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med. 5 1999 601 604
34. M.A. Atkinson Insulitis and diabetes in NOD mice reduced by prohylactic insulin therapy Diabetes 39 1990 933 937
35. C.F. Gotfredsen Reduction of diabetes incidence of BB rats by early prophylactic insulin treatment of diabetes-prone animals Diabetologia 28 1985 933
36. P.A. Gottlieb Insulin treatment prevents diabetes mellitus but not thyroiditis in RT6-depleted diabetes resistant BB/Wor rats Diabetologia 34 1991 296 300
37. + regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells J. Autoimmun. 21 2003 221 237
38. Diabetes Prevention Trial-Type 1 Study Group Effects of insulin in relatives of patients with type 1 diabetes mellitus New Engl. J. Med. 346 2002 1685 1691
39. D.G. Karounas Dose of insulin is a critical factor in the prevention of type 1 diabetes in the NOD mouse Diabetes 52 Suppl. 2 2003 A276
40. Diabetes Prevention Trial-Type 1 Study Group Effects of oral insulin in relatives of patients with type 1 diabetes: The diabetes prevention trial-type 1 Diabetes Care 28 2005 1068 1076
41. M. Nakayama Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice Nature 435 2005 220 223
42. S.C. Kent Expanded T cells from pancreatic lymph nodes of type 1 diabetic subjects recognize an insulin epitope Nature 435 2005 224 228
43. S.M. Lieberman, and T.P. DiLorenzo A comprehensive guide to antibody and T cell responses in type 1 diabetes Tissue Antigens 62 2003 359 377
44. D. Devendra Endocrine autoantibodies Clin. Lab. Med. 24 2004 275 303
45. J.S. Petersen Treatment with GAD or BSA does not protect against diabetes in BB rats Autoimmunity 25 1997 129 138
46. J.S. Petersen Differential expression of glutamic acid decarboxylase in rat and human islets Diabetes 42 1993 484 495
47. 67 in human, rat, and mouse, pancreatic islets Diabetes 42 1993 1799 1808
48. M. Bridgett Differential protection in two transgenic lines of NOD/Lt mice hyperexpressing the autoantigen GAD65 in pancreatic beta cells Diabetes 47 1998 1848 1856
49. S. Winer Autoimmune islet destruction in spontaneous type 1 diabetes is not β-cell exclusive Nat. Med. 9 2003 198 205
50. E. Jaeckel Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylase J. Exp. Med. 197 2003 1635 1644
51. M. Vaysburd Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides J. Exp. Med. 182 1995 897 902
52. F.S. Wong Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library Nat. Med. 5 1999 1026 1031
53. S.M. Lieberman Identification of the novel β cell antigen targeted by a prevalent population of pathogenic CD8 T cells in autoimmune diabetes Proc. Natl. Acad. Sci. U. S. A. 100 2003 8384 8388
54. S.M. Lieberman Individual nonobese diabetic mice exhibit unique patterns of CD8 T cell reactivity to three islet antigens including the newly identified widely expressed dystrophia myotonica kinase J. Immunol. 173 2004 6727 6734
55. K.C. Herold A single course of anti-CD3 monoclonal antibody hOKT3γ1 (Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least two years after onset of type 1 diabetes Diabetes 54 2005 1763 1769
56. E. Seung Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice Blood 95 2000 2175 2182
57. B. Nikolic Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity Diabetes 53 2004 376 383
58. Y-G. Chen Autoimmune diabetes prevention by NKT-cell activation involves tolerogenic recruitment of both dendritic cells and T cells to pancreatic lymph nodes J. Immunol. 174 2005 1196 1204
59. S.B. Wilson, and T.L. Delovitch Janus-like role of regulatory iNKT cells in autoimmune disease and tumor immunity Nat. Rev. Immunol. 3 2003 211 222
60. K. Shortman, and Y.J. Liu Mouse and human dendritic cell subtypes Nat. Rev. Immunol. 2 2002 151 161
61. R.M. Steinman Tolerogenic dendritic cells Annu. Rev. Immunol. 21 2003 685 711
62. + T cells J. Exp. Med. 186 1997 239 245
63. C. Kurts Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo J. Immunol. 166 2001 1439 1442
64. M.L. Albert Dendritic cell maturation is required for the cross tolerization of CD8 T cells Nat. Immunol. 2 2001 1010 1017